Trial Profile
Nimotuzumab Combined With Radiotherapy for Older Patients With Esophageal Cancer: a Single, Non-control Phase II Clinical Trial
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Sep 2023
Price :
$35
*
At a glance
- Drugs Nimotuzumab (Primary)
- Indications Oesophageal cancer
- Focus Adverse reactions
- 02 Feb 2021 Status changed from active, no longer recruiting to completed.
- 04 Nov 2011 New trial record